| Year |
Citation |
Score |
| 2024 |
Fonseca CS, Baker SL, Dobyns L, Janabi M, Jagust WJ, Harrison TM. Tau accumulation and atrophy predict amyloid independent cognitive decline in aging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38334195 DOI: 10.1002/alz.13654 |
0.336 |
|
| 2024 |
Landau SM, Lee J, Murphy A, Ward TJ, Harrison TM, Baker SL, DeCarli C, Harvey D, Tosun D, Weiner MW, Koeppe RA, Jagust WJ. Individuals with Alzheimer's disease and low tau burden: Characteristics and implications. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38241084 DOI: 10.1002/alz.13609 |
0.333 |
|
| 2023 |
Blazhenets G, Soleimani-Meigooni DN, Thomas W, Mundada N, Brendel M, Vento S, VandeVrede L, Heuer HW, Ljubenkov P, Rojas JC, Chen MK, Amuiri AN, Miller Z, Gorno-Tempini ML, Miller BL, ... ... Baker SL, et al. [F]PI-2620 Binding Patterns in Patients with Suspected Alzheimer Disease and Frontotemporal Lobar Degeneration. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 37918868 DOI: 10.2967/jnumed.123.265856 |
0.368 |
|
| 2023 |
Chen X, Toueg TN, Harrison TM, Baker SL, Jagust WJ. Regional Tau Deposition Reflects Different Pathways of Subsequent Neurodegeneration and Memory Decline in Cognitively Normal Older Adults. Annals of Neurology. PMID 37789559 DOI: 10.1002/ana.26813 |
0.351 |
|
| 2023 |
Han F, Lee J, Chen X, Ziontz J, Ward T, Landau SM, Baker SL, Harrison TM, Jagust WJ. Global brain activity and its coupling with cerebrospinal fluid flow is related to tau pathology. Biorxiv : the Preprint Server For Biology. PMID 37745434 DOI: 10.1101/2023.09.12.557492 |
0.308 |
|
| 2022 |
Harrison TM, Ward TJ, Murphy A, Baker SL, Dominguez PA, Koeppe R, Vemuri P, Lockhart SN, Jung Y, Harvey DJ, Lovato L, Toga AW, Masdeu J, Oh H, Gitelman DR, et al. Optimizing quantification of MK6240 tau PET in unimpaired older adults. Neuroimage. 119761. PMID 36455762 DOI: 10.1016/j.neuroimage.2022.119761 |
0.376 |
|
| 2022 |
Tissot C, Servaes S, Lussier FZ, Ferrari-Souza JP, Therriault J, Ferreira PCL, Bezgin G, Bellaver B, Teixeira Leffa D, Mathotaarachchi SS, Chamoun M, Stevenson J, Rahmouni N, Kang MS, Pallen V, ... ... Baker SL, et al. The association of age-related and off-target retention with longitudinal quantification of [F]MK6240 tau-PET in target regions. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 36396455 DOI: 10.2967/jnumed.122.264434 |
0.314 |
|
| 2022 |
Zhuang K, Chen X, Cassady KE, Baker SL, Jagust WJ. Metacognition, cortical thickness, and tauopathy in aging. Neurobiology of Aging. 118: 44-54. PMID 35868093 DOI: 10.1016/j.neurobiolaging.2022.06.007 |
0.313 |
|
| 2022 |
LaPoint MR, Baker SL, Landau SM, Harrison TM, Jagust WJ. Rates of β-amyloid deposition indicate widespread simultaneous accumulation throughout the brain. Neurobiology of Aging. 115: 1-11. PMID 35447369 DOI: 10.1016/j.neurobiolaging.2022.03.005 |
0.374 |
|
| 2022 |
Meyer PF, Ashton NJ, Karikari TK, Strikwerda-Brown C, Köbe T, Gonneaud J, Pichet Binette A, Ozlen H, Yakoub Y, Simrén J, Pannee J, Lantero-Rodriguez J, Labonté A, Baker SL, Schöll M, et al. Plasma p-tau231, p-tau181, PET biomarkers and cognitive change in older adults. Annals of Neurology. PMID 35084051 DOI: 10.1002/ana.26308 |
0.338 |
|
| 2022 |
Ciampa CJ, Parent JH, Harrison TM, Fain RM, Betts MJ, Maass A, Winer JR, Baker SL, Janabi M, Furman DJ, D'Esposito M, Jagust WJ, Berry AS. Associations among locus coeruleus catecholamines, tau pathology, and memory in aging. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 35034099 DOI: 10.1038/s41386-022-01269-6 |
0.414 |
|
| 2021 |
Adams JN, Harrison TM, Maass A, Baker SL, Jagust WJ. Distinct factors drive the spatiotemporal progression of tau pathology in older adults. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 34965972 DOI: 10.1523/JNEUROSCI.1601-21.2021 |
0.353 |
|
| 2021 |
Teng E, Manser PT, Sanabria Bohorquez S, Wildsmith KR, Pickthorn K, Baker SL, Ward M, Kerchner GA, Weimer RM. Baseline [F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer's disease. Alzheimer's Research & Therapy. 13: 196. PMID 34852837 DOI: 10.1186/s13195-021-00937-x |
0.392 |
|
| 2021 |
Ziontz J, Adams JN, Harrison TM, Baker SL, Jagust WJ. Hippocampal connectivity with retrosplenial cortex is linked to neocortical tau accumulation and memory function. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 34531286 DOI: 10.1523/JNEUROSCI.0990-21.2021 |
0.364 |
|
| 2021 |
Strom A, Iaccarino L, Edwards L, Lesman-Segev OH, Soleimani-Meigooni DN, Pham J, Baker SL, Landau S, Jagust WJ, Miller BL, Rosen HJ, Gorno-Tempini ML, Rabinovici GD, La Joie R. Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease. Brain : a Journal of Neurology. PMID 34373896 DOI: 10.1093/brain/awab294 |
0.439 |
|
| 2021 |
Baker SL, Provost K, Thomas W, Whitman AJ, Janabi M, Schmidt ME, Timmers M, Kolb HC, Rabinovici GD, Jagust WJ. Evaluation of [F]-JNJ-64326067-AAA tau PET tracer in humans. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X211031035. PMID 34259071 DOI: 10.1177/0271678X211031035 |
0.396 |
|
| 2021 |
Ossenkoppele R, Smith R, Mattsson-Carlgren N, Groot C, Leuzy A, Strandberg O, Palmqvist S, Olsson T, Jögi J, Stormrud E, Cho H, Ryu YH, Choi JY, Boxer AL, Gorno-Tempini ML, ... ... Baker S, et al. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging. Jama Neurology. PMID 34180956 DOI: 10.1001/jamaneurol.2021.1858 |
0.305 |
|
| 2021 |
Edwards L, La Joie R, Iaccarino L, Strom A, Baker SL, Casaletto KB, Cobigo Y, Grant H, Kim M, Kramer JH, Mellinger TJ, Pham J, Possin KL, Rosen HJ, Soleimani-Meigooni DN, et al. Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females. Neurobiology of Aging. 105: 86-98. PMID 34049062 DOI: 10.1016/j.neurobiolaging.2021.04.003 |
0.392 |
|
| 2021 |
Cassady KE, Adams JN, Chen X, Maass A, Harrison TM, Landau S, Baker S, Jagust W. Alzheimer's Pathology Is Associated with Dedifferentiation of Intrinsic Functional Memory Networks in Aging. Cerebral Cortex (New York, N.Y. : 1991). PMID 34037210 DOI: 10.1093/cercor/bhab122 |
0.332 |
|
| 2021 |
Adams JN, Maass A, Berron D, Harrison TM, Baker SL, Thomas WP, Stanfill M, Jagust WJ. Reduced repetition suppression in aging is driven by tau-related hyperactivity in medial temporal lobe. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 33731446 DOI: 10.1523/JNEUROSCI.2504-20.2021 |
0.375 |
|
| 2021 |
Provost K, La Joie R, Strom A, Iaccarino L, Edwards L, Mellinger TJ, Pham J, Baker SL, Miller BL, Jagust WJ, Rabinovici GD. Crossed cerebellar diaschisis on F-FDG PET: Frequency across neurodegenerative syndromes and association with C-PIB and F-Flortaucipir. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X211001216. PMID 33691512 DOI: 10.1177/0271678X211001216 |
0.315 |
|
| 2021 |
Provost K, Iaccarino L, Soleimani-Meigooni DN, Baker S, Edwards L, Eichenlaub U, Hansson O, Jagust W, Janabi M, La Joie R, Lesman-Segev O, Mellinger TJ, Miller BL, Ossenkoppele R, Pham J, et al. Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33398408 DOI: 10.1007/s00259-020-05152-8 |
0.343 |
|
| 2020 |
Harrison TM, Du R, Klencklen G, Baker SL, Jagust WJ. Distinct effects of beta-amyloid and tau on cortical thickness in cognitively healthy older adults. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33325068 DOI: 10.1002/alz.12249 |
0.319 |
|
| 2020 |
Sonni I, Lesman Segev OH, Baker SL, Iaccarino L, Korman D, Rabinovici GD, Jagust WJ, Landau SM, La Joie R. Evaluation of a visual interpretation method for tau-PET with F-flortaucipir. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12133. PMID 33313377 DOI: 10.1002/dad2.12133 |
0.349 |
|
| 2020 |
La Joie R, Visani AV, Lesman-Segev OH, Baker SL, Edwards L, Iaccarino L, Soleimani-Meigooni DN, Mellinger T, Janabi M, Miller ZA, Perry DC, Pham J, Strom A, Gorno-Tempini ML, Rosen HJ, et al. Association of APOE4 and clinical variability in Alzheimer disease with the pattern of tau- and amyloid-PET. Neurology. PMID 33262228 DOI: 10.1212/WNL.0000000000011270 |
0.386 |
|
| 2020 |
Chen X, Cassady K, Adams JN, Harrison TM, Baker SL, Jagust WJ. Regional Tau Effects on Prospective Cognitive Change in Cognitively Normal Older Adults. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 33219003 DOI: 10.1523/JNEUROSCI.2111-20.2020 |
0.387 |
|
| 2020 |
Yoon B, Baker SL, Korman D, Tennant VR, Harrison TM, Landau S, Jagust WJ. Conscientiousness is associated with less amyloid deposition in cognitively normal aging. Psychology and Aging. 35: 993-999. PMID 33166168 DOI: 10.1037/pag0000582 |
0.317 |
|
| 2020 |
Soleimani-Meigooni DN, Iaccarino L, La Joie R, Baker S, Bourakova V, Boxer AL, Edwards L, Eser R, Gorno-Tempini ML, Jagust WJ, Janabi M, Kramer JH, Lesman-Segev OH, Mellinger T, Miller BL, et al. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases. Brain : a Journal of Neurology. PMID 33141172 DOI: 10.1093/brain/awaa276 |
0.434 |
|
| 2020 |
Guo T, Korman D, Baker SL, Landau SM, Jagust WJ. Longitudinal Cognitive and Biomarker Measurements Support a Unidirectional Pathway in Alzheimer's Disease Pathophysiology. Biological Psychiatry. PMID 32919611 DOI: 10.1016/J.Biopsych.2020.06.029 |
0.421 |
|
| 2020 |
Winer JR, Mander BA, Kumar S, Reed M, Baker SL, Jagust WJ, Walker MP. Sleep Disturbance Forecasts β-Amyloid Accumulation across Subsequent Years. Current Biology : Cb. PMID 32888482 DOI: 10.1016/J.Cub.2020.08.017 |
0.307 |
|
| 2020 |
Iaccarino L, La Joie R, Edwards L, Strom A, Schonhaut DR, Ossenkoppele R, Pham J, Mellinger T, Janabi M, Baker SL, Soleimani-Meigooni D, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD. Spatial Relationships between Molecular Pathology and Neurodegeneration in the Alzheimer's Disease Continuum. Cerebral Cortex (New York, N.Y. : 1991). PMID 32808011 DOI: 10.1093/Cercor/Bhaa184 |
0.51 |
|
| 2020 |
Cho SH, Choe YS, Kim HJ, Jang H, Kim Y, Kim SE, Kim SJ, Kim JP, Jung YH, Kim BC, Baker SL, Lockhart SN, Na DL, Park S, Seo SW. Correction to: A new Centiloid method for F-florbetaben and F-flutemetamol PET without conversion to PiB. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32055964 DOI: 10.1007/S00259-020-04692-3 |
0.32 |
|
| 2020 |
Pereira JB, Harrison TM, La Joie R, Baker SL, Jagust WJ. Spatial patterns of tau deposition are associated with amyloid, ApoE, sex, and cognitive decline in older adults. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31915896 DOI: 10.1007/S00259-019-04669-X |
0.403 |
|
| 2020 |
La Joie R, Visani AV, Baker SL, Brown JA, Bourakova V, Cha J, Chaudhary K, Edwards L, Iaccarino L, Janabi M, Lesman-Segev OH, Miller ZA, Perry DC, O'Neil JP, Pham J, et al. Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET. Science Translational Medicine. 12. PMID 31894103 DOI: 10.1126/Scitranslmed.Aau5732 |
0.494 |
|
| 2020 |
Soleimani‐Meigooni DN, Iaccarino L, La Joie R, Baker SL, Bourakova V, Boxer AL, Edwards L, Eser RA, Tempini MLG, Jagust WJ, Janabi M, kramer JH, Lesman‐Segev OH, Mellinger TJ, Miller BL, et al. [
18
F]Flortaucipir PET to autopsy pathology comparisons in Alzheimer’s disease and other neurodegenerative diseases Alzheimer's & Dementia. 16. DOI: 10.1002/ALZ.046262 |
0.303 |
|
| 2019 |
Cho SH, Choe YS, Kim HJ, Jang H, Kim Y, Kim SE, Kim SJ, Kim JP, Jung YH, Kim BC, Baker SL, Lockhart SN, Na DL, Park S, Seo SW. A new Centiloid method for F-florbetaben and F-flutemetamol PET without conversion to PiB. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31834446 DOI: 10.1007/S00259-019-04596-X |
0.328 |
|
| 2019 |
Harrison TM, Maass A, Adams JN, Du R, Baker SL, Jagust WJ. Tau deposition is associated with functional isolation of the hippocampus in aging. Nature Communications. 10: 4900. PMID 31653847 DOI: 10.1038/S41467-019-12921-Z |
0.371 |
|
| 2019 |
Adams JN, Maass A, Harrison TM, Baker SL, Jagust WJ. Cortical tau deposition follows patterns of entorhinal functional connectivity in aging. Elife. 8. PMID 31475904 DOI: 10.7554/Elife.49132 |
0.451 |
|
| 2019 |
Teng E, Ward M, Manser PT, Sanabria-Bohorquez S, Ray RD, Wildsmith KR, Baker S, Kerchner GA, Weimer RM. Cross-sectional associations between [F]GTP1 tau PET and cognition in Alzheimer's disease. Neurobiology of Aging. 81: 138-145. PMID 31280117 DOI: 10.1016/j.neurobiolaging.2019.05.026 |
0.409 |
|
| 2019 |
Winer JR, Mander BA, Helfrich RF, Maass A, Harrison TM, Baker SL, Knight RT, Jagust WJ, Walker MP. Sleep as a potential biomarker of tau and β-amyloid burden in the human brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 31209175 DOI: 10.1523/Jneurosci.0503-19.2019 |
0.354 |
|
| 2019 |
Shokouhi S, Conley AC, Baker SL, Albert K, Kang H, Gwirtsman HE, Newhouse PA. The relationship between domain-specific subjective cognitive decline and Alzheimer's pathology in normal elderly adults. Neurobiology of Aging. 81: 22-29. PMID 31207466 DOI: 10.1016/J.Neurobiolaging.2019.05.011 |
0.452 |
|
| 2019 |
Maass A, Berron D, Harrison TM, Adams JN, La Joie R, Baker S, Mellinger T, Bell RK, Swinnerton K, Inglis B, Rabinovici GD, Düzel E, Jagust WJ. Alzheimer's pathology targets distinct memory networks in the ageing brain. Brain : a Journal of Neurology. PMID 31199481 DOI: 10.1093/Brain/Awz154 |
0.487 |
|
| 2019 |
Ossenkoppele R, Iaccarino L, Schonhaut DR, Brown JA, La Joie R, O'Neil JP, Janabi M, Baker SL, Kramer JH, Gorno-Tempini ML, Miller BL, Rosen HJ, Seeley WW, Jagust WJ, Rabinovici GD. Tau covariance patterns in Alzheimer's disease patients match intrinsic connectivity networks in the healthy brain. Neuroimage. Clinical. 23: 101848. PMID 31077982 DOI: 10.1016/J.Nicl.2019.101848 |
0.466 |
|
| 2019 |
Baker SL, Harrison TM, Maaß A, La Joie R, Jagust W. Effect of off-target binding on F-Flortaucipir variability in healthy controls across the lifespan. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30877180 DOI: 10.2967/Jnumed.118.224113 |
0.405 |
|
| 2019 |
Tsai RM, Bejanin A, Lesman-Segev O, LaJoie R, Visani A, Bourakova V, O'Neil JP, Janabi M, Baker S, Lee SE, Perry DC, Bajorek L, Karydas A, Spina S, Grinberg LT, et al. F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes. Alzheimer's Research & Therapy. 11: 13. PMID 30704514 DOI: 10.1186/S13195-019-0470-7 |
0.485 |
|
| 2019 |
Adams JN, Maass A, Harrison TM, Baker SL, Jagust WJ. Author response: Cortical tau deposition follows patterns of entorhinal functional connectivity in aging Elife. DOI: 10.7554/Elife.49132.026 |
0.33 |
|
| 2019 |
Harrison TM, Becerra M, Winer JR, Baker SL, Grothe MJ, Jagust WJ. O4-12-02: Tau Pathology And Cognition Are Related To Basal Forebrain Degeneration In Aging Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4807 |
0.35 |
|
| 2019 |
Maass A, Harrison TM, Berron D, Adams JN, Joie RL, Baker SL, Düzel E, Jagust WJ. F4-02-02: Tau Pet Imaging In Aging: Contributions To Cognitive Decline And Neural Dysfunction Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4719 |
0.428 |
|
| 2019 |
Baker SL. F4-02-01: Trials And Tribulations Of Tau Pet Imaging Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4718 |
0.392 |
|
| 2019 |
Pereira JB, Harrison TM, Joie RL, Baker SL, Jagust WJ. Ic-P-172: Spatial Patterns Of Tau Deposition In Aging Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4287 |
0.332 |
|
| 2019 |
Baker SL, Joie RL, Liu C, Cobigo Y, Bourakova V, Harrison TM, Rabinovici GD, Jagust WJ. Ic-04-04: Iron, Neurodegeneration, Tau, And Amyloid In Patients With Alzheimer'S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4154 |
0.389 |
|
| 2019 |
Soleimani-Meigooni DN, Iaccarino L, La Joie R, Lesman-Segev OH, Bourakova V, Strom A, Edwards L, Baker SL, Janabi M, Eser R, Larsen E, Spina S, Seeley WW, Grinberg LT, Jagust WJ, et al. P2-439: [18
F]FLORTAUCIPIR PET AND PATHOLOGY CORRELATIONS IN ALZHEIMER'S DISEASE, NON-ALZHEIMER'S TAUOPATHIES, AND OTHER NEURODEGENERATIVE DISEASES Alzheimer's & Dementia. 15: P782-P782. DOI: 10.1016/J.Jalz.2019.06.2846 |
0.47 |
|
| 2019 |
Harrison TM, Adams JN, Maass A, Du R, Baker SL, Jagust WJ. P2-353: Signal Coherence In The Hippocampus Is Related To Its Functional Isolation, Preclinical Alzheimer'S Disease Pathology And Memory In Aging Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2760 |
0.383 |
|
| 2019 |
Iaccarino L, Schonhaut DR, La Joie R, Ossenkoppele R, Bejanin A, Edwards L, Tammewar G, Pham JQ, Chaudhary K, Janabi M, Baker SL, Miller BL, Jagust WJ, Rabinovici GD. P2-336: SPATIAL DISTRIBUTION AND TOPOGRAPHICAL RELATIONSHIPS OF PATHOLOGY AND NEURODEGENERATION IN ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P720-P721. DOI: 10.1016/J.Jalz.2019.06.2743 |
0.373 |
|
| 2018 |
Harrison TM, La Joie R, Maass A, Baker SL, Swinnerton K, Fenton L, Mellinger TJ, Edwards L, Pham J, Miller BL, Rabinovici GD, Jagust WJ. Longitudinal tau accumulation and atrophy in aging and Alzheimer's disease. Annals of Neurology. PMID 30597624 DOI: 10.1002/Ana.25406 |
0.457 |
|
| 2018 |
He M, Baker SL, Shah VD, Lockhart SN, Jagust WJ. Scan-time Corrections for 80-100 Minute Standardized Uptake Volume Ratios to Measure the 18F-AV-1451 Tracer for Tau Imaging. Ieee Transactions On Medical Imaging. PMID 30235119 DOI: 10.1109/Tmi.2018.2870441 |
0.379 |
|
| 2018 |
Harrison TM, Maass A, Baker SL, Jagust WJ. Brain morphology, cognition, and β-amyloid in older adults with superior memory performance. Neurobiology of Aging. 67: 162-170. PMID 29665578 DOI: 10.1016/J.Neurobiolaging.2018.03.024 |
0.354 |
|
| 2018 |
Iaccarino L, Tammewar G, Ayakta N, Baker SL, Bejanin A, Boxer AL, Gorno-Tempini ML, Janabi M, Kramer JH, Lazaris A, Lockhart SN, Miller BL, Miller ZA, O'Neil JP, Ossenkoppele R, et al. Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease. Neuroimage. Clinical. 17: 452-464. PMID 29159058 DOI: 10.1016/J.Nicl.2017.09.016 |
0.493 |
|
| 2018 |
Harrison TM, Joie RL, Maass A, Baker SL, Rabinovici GD, Jagust WJ. O4-09-04: Longitudinal Tau-Pet And Atrophy In Healthy Older Adults And In Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2960 |
0.428 |
|
| 2018 |
Vogel JW, Ossenkoppele R, Kiar G, Medina YI, Baker SL, Hansson O, Evans AC, Initiative ADN. Ic-P-224: Heterogeneous Tau-Pet Signal In The Hippocampus Helps Resolve Discrepancies Between Imaging And Pathology Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2291 |
0.394 |
|
| 2018 |
Harrison TM, Joie RL, Maass A, Baker SL, Rabinovici GD, Jagust WJ. Ic-P-205: Longitudinal Tau-Pet And Atrophy In Healthy Older Adults And Those With Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2272 |
0.449 |
|
| 2018 |
Maass A, Berron D, Harrison TM, Baker SL, Mellinger TJ, Swinnerton KN, Bell RK, Düzel E, Jagust WJ, Adams JN. F1-04-04: Effects Of Tau And Amyloid Deposition Measured By Pet On Domain-Specific Memory Function In Old Age Alzheimers & Dementia. 14: 87. DOI: 10.1016/J.Jalz.2018.06.2167 |
0.434 |
|
| 2018 |
Sonni I, Lesman-Segev OH, Maass A, Baker SL, Korman D, Rabinovici GD, Jagust WJ. P2-373: Evaluation Of Visual Interpretation Methods For Tau Pet Imaging Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1064 |
0.37 |
|
| 2017 |
La Joie R, Bejanin A, Fagan AM, Ayakta N, Baker SL, Bourakova V, Boxer AL, Cha J, Karydas A, Jerome G, Maass A, Mensing A, Miller ZA, O'Neil JP, Pham J, et al. Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample. Neurology. PMID 29282337 DOI: 10.1212/Wnl.0000000000004860 |
0.398 |
|
| 2017 |
Winer JR, Maass A, Pressman P, Stiver J, Schonhaut DR, Baker SL, Kramer J, Rabinovici GD, Jagust WJ. Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease. Jama Neurology. PMID 29228071 DOI: 10.1001/Jamaneurol.2017.3713 |
0.371 |
|
| 2017 |
Maass A, Lockhart SN, Harrison TM, Bell RK, Mellinger T, Swinnerton K, Baker SL, Rabinovici GD, Jagust WJ. Entorhinal tau pathology, episodic memory decline and neurodegeneration in aging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29192126 DOI: 10.1523/Jneurosci.2028-17.2017 |
0.469 |
|
| 2017 |
Baker SL, Maass A, Jagust WJ. Considerations and code for partial volume correcting [(18)F]-AV-1451 tau PET data. Data in Brief. 15: 648-657. PMID 29124088 DOI: 10.1016/J.Dib.2017.10.024 |
0.431 |
|
| 2017 |
Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, Ayakta N, Cantwell A, Janabi M, Lauriola M, O'Neil JP, Gorno-Tempini ML, Miller ZA, Rosen HJ, Miller BL, et al. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease. Brain : a Journal of Neurology. PMID 29053874 DOI: 10.1093/Brain/Awx243 |
0.494 |
|
| 2017 |
Schonhaut DR, McMillan CT, Spina S, Dickerson BC, Siderowf A, Devous MD, Tsai R, Winer J, Russell DS, Litvan I, Roberson ED, Seeley WW, Grinberg LT, Kramer JH, Miller BL, ... ... Baker SL, et al. (18) F-flortaucipir tau PET distinguishes established progressive supranuclear palsy from controls and Parkinson's disease: A multicenter study. Annals of Neurology. PMID 28980714 DOI: 10.1002/Ana.25060 |
0.424 |
|
| 2017 |
Maass A, Landau S, Baker SL, Horng A, Lockhart SN, Joie R, Rabinovici GD, Jagust WJ. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's Disease. Neuroimage. PMID 28587897 DOI: 10.1016/J.Neuroimage.2017.05.058 |
0.514 |
|
| 2017 |
Lockhart SN, Schöll M, Baker SL, Ayakta N, Swinnerton KN, Bell RK, Mellinger TJ, Shah VD, O'Neil JP, Janabi M, Jagust WJ. Amyloid and Tau PET Demonstrate Region-Specific Associations in Normal Older People. Neuroimage. PMID 28232190 DOI: 10.1016/J.Neuroimage.2017.02.051 |
0.463 |
|
| 2017 |
Marks SM, Lockhart SN, Baker SL, Jagust WJ. Tau and β-amyloid are associated with medial temporal lobe structure, function and memory encoding in normal aging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28213439 DOI: 10.1523/Jneurosci.3769-16.2017 |
0.444 |
|
| 2017 |
Harrison TM, Lockhart SN, Baker SL, Jagust WJ. THE ROLE OF β-AMYLOID IN SUPERAGERS WITH SUPERIOR MEMORY PERFORMANCE AND PRESERVED BRAIN MORPHOMETRY Alzheimer's & Dementia. 13: P1463-P1464. DOI: 10.1016/J.Jalz.2017.07.532 |
0.308 |
|
| 2017 |
Lockhart SN, Adams JN, Baker SL, Kang J, Li L, Jagust WJ. EFFECTS OF TAU DEPOSITION ON CEREBRAL GLUCOSE METABOLISM IN NORMAL OLDER ADULTS VARY BY AMYLOID LEVEL Alzheimer's & Dementia. 13: P202. DOI: 10.1016/J.Jalz.2017.07.066 |
0.339 |
|
| 2017 |
La Joie R, Bourakova V, Visani A, Bejanin A, Ayakta N, Baker SL, Karydas A, Coppola G, Mensing A, Pham J, Rosen H, Miller BL, Jagust WJ, Rabinovici GD. [P1-414]: DOES APOE ε4 HAVE AN Aβ-INDEPENDENT EFFECT ON TAU PATHOLOGY? NEUROIMAGING INVESTIGATIONS IN COGNITIVELY NORMAL ELDERS AND PATIENTS WITH ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P435-P436. DOI: 10.1016/j.jalz.2017.06.430 |
0.347 |
|
| 2017 |
La Joie R, Visani A, Bourakova V, Baker SL, Ayakta N, Pham J, Mensing A, Rosen H, Miller BL, Jagust WJ, Rabinovici GD. [IC-01-01]: AV1451-PET CORTICAL UPTAKE AND REGIONAL DISTRIBUTION PREDICTS LONGITUDINAL ATROPHY IN ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P1-P1. DOI: 10.1016/J.Jalz.2017.06.2621 |
0.41 |
|
| 2017 |
La Joie R, Bejanin A, Fagan AM, Ayakta N, Baker SL, Bourakova V, Karydas A, Jerome G, O'Neil JP, Pham J, Visani A, Rosen H, Boxer A, Miller BL, Jagust WJ, et al. AV1451-PET UPTAKE AND CSF BIOMARKERS IN A HETEROGENEOUS CLINICAL SAMPLE: TWO SIDES OF THE SAME COIN? Alzheimer's & Dementia. 13: P137-P138. DOI: 10.1016/J.Jalz.2017.06.2561 |
0.309 |
|
| 2017 |
Bejanin A, Schonhaut DR, La Joie R, Kramer JH, Baker SL, Sosa N, Ayakta N, Cantwell A, Janabi M, Lauriola M, O'Neil JP, Gorno-Tempini M, Miller ZA, Rosen HJ, Miller BL, et al. [IC-P-176]: TAU PATHOLOGY AND GRAY MATTER ATROPHY CONTRIBUTE TO COGNITIVE IMPAIRMENT IN ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P131-P131. DOI: 10.1016/J.Jalz.2017.06.2551 |
0.421 |
|
| 2017 |
Maass A, Lockhart SN, Mellinger TJ, Bell RK, Baker SL, Jagust WJ. [IC-P-124]: MEDIAL TEMPORAL LOBE TAU IS STRONGLY RELATED TO EPISODIC MEMORY DECLINE IN AGING Alzheimer's & Dementia. 13: P94-P95. DOI: 10.1016/J.Jalz.2017.06.2398 |
0.353 |
|
| 2017 |
La Joie R, Bourakova V, Visani A, Bejanin A, Ayakta N, Baker SL, Karydas A, Coppola G, Mensing A, Pham J, Rosen H, Miller BL, Jagust WJ, Rabinovici GD. [IC-P-059]: DOES APOE-ε4 HAVE AN Aβ-INDEPENDENT EFFECT ON TAU PATHOLOGY? NEUROIMAGING INVESTIGATIONS IN COGNITIVELY NORMAL ELDERS AND PATIENTS WITH ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P48-P49. DOI: 10.1016/J.Jalz.2017.06.2332 |
0.446 |
|
| 2017 |
Baker SL, Lockhart SN, Maass A, Jagust WJ. [P4-052]: PARTIAL VOLUME EFFECTS AND MEDIAL TEMPORAL LOBE TAU QUANTITATION WITH PET Alzheimer's & Dementia. 13: P1277-P1277. DOI: 10.1016/J.Jalz.2017.06.1917 |
0.391 |
|
| 2017 |
La Joie R, Visani A, Bourakova V, Baker SL, Ayakta N, Pham J, Mensing A, Rosen H, Miller BL, Jagust WJ, Rabinovici GD. [P2-373]: AV1451-PET CORTICAL UPTAKE AND REGIONAL DISTRIBUTION PREDICT LONGITUDINAL ATROPHY IN ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P769-P769. DOI: 10.1016/j.jalz.2017.06.1028 |
0.319 |
|
| 2017 |
La Joie R, Bourakova V, Visani A, Bejanin A, Ayakta N, Baker SL, Karydas A, Coppola G, Mensing A, Pham J, Rosen H, Miller BL, Jagust WJ, Rabinovici GD. [P1-031]: DOES APOE-ε4 HAVE AN Aβ-INDEPENDENT EFFECT ON TAU PATHOLOGY? NEUROIMAGING INVESTIGATIONS IN COGNITIVELY NORMAL ELDERS AND PATIENTS WITH ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P245-P246. DOI: 10.1016/j.jalz.2017.06.098 |
0.347 |
|
| 2016 |
Berry AS, Shah VD, Baker SL, Vogel JW, O'Neil JP, Janabi M, Schwimmer HD, Marks SM, Jagust WJ. Aging affects dopaminergic neural mechanisms of cognitive flexibility. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 27807030 DOI: 10.1523/Jneurosci.0626-16.2016 |
0.329 |
|
| 2016 |
Baker SL, Lockhart SN, Price JC, He M, Huesman RH, Schonhaut D, Faria J, Rabinovici G, Jagust WJ. Reference tissue-based kinetic evaluation of 18F-AV-1451 in aging and dementia. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27587706 DOI: 10.2967/Jnumed.116.175273 |
0.484 |
|
| 2016 |
Lockhart SN, Baker SL, Okamura N, Furukawa K, Ishiki A, Furumoto S, Tashiro M, Yanai K, Arai H, Kudo Y, Harada R, Tomita N, Hiraoka K, Watanuki S, Jagust WJ. Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351. Plos One. 11: e0158460. PMID 27355840 DOI: 10.1371/Journal.Pone.0158460 |
0.497 |
|
| 2016 |
Oh H, Madison C, Baker S, Rabinovici G, Jagust W. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease. Brain : a Journal of Neurology. PMID 27190008 DOI: 10.1093/Brain/Aww108 |
0.42 |
|
| 2016 |
Ossenkoppele R, Schonhaut DR, Schöll M, Lockhart SN, Ayakta N, Baker SL, O'Neil JP, Janabi M, Lazaris A, Cantwell A, Vogel J, Santos M, Miller ZA, Bettcher BM, Vossel KA, et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Brain : a Journal of Neurology. PMID 26962052 DOI: 10.1093/Brain/Aww027 |
0.517 |
|
| 2016 |
Schöll M, Lockhart SN, Schonhaut DR, O'Neil JP, Janabi M, Ossenkoppele R, Baker SL, Vogel JW, Faria J, Schwimmer HD, Rabinovici GD, Jagust WJ. PET Imaging of Tau Deposition in the Aging Human Brain. Neuron. 89: 971-82. PMID 26938442 DOI: 10.1016/J.Neuron.2016.01.028 |
0.513 |
|
| 2016 |
Shokouhi S, Mckay JW, Baker SL, Kang H, Brill AB, Gwirtsman HE, Riddle WR, Claassen DO, Rogers BP. Reference tissue normalization in longitudinal (18)F-florbetapir positron emission tomography of late mild cognitive impairment. Alzheimer's Research & Therapy. 8: 2. PMID 26768154 DOI: 10.1186/S13195-016-0172-3 |
0.403 |
|
| 2016 |
Lockhart SN, Schöll M, Mellinger TJ, Swinnerton KN, Bell RK, O'Neil JP, Janabi M, Baker SL, Jagust WJ. O4-01-05: Examining Amyloid and Tau Inter-Regional Pet Association Patterns in Cognitively Normal Older Adults Alzheimer's & Dementia. 12: P332-P333. DOI: 10.1016/j.jalz.2016.06.610 |
0.303 |
|
| 2016 |
Ossenkoppele R, Schonhaut DR, Brown J, O'Neil JP, Janabi M, Baker SL, Schöll M, Kramer J, Gorno Tempini M, Miller B, Seeley WW, Jagust WJ, Rabinovici GD. O3-08-04: Tau Covariance Patterns in Alzheimer's Disease Patients Resemble Intrinsic Connectivity Networks in Young Adults Alzheimer's & Dementia. 12: P305-P306. DOI: 10.1016/J.Jalz.2016.06.552 |
0.365 |
|
| 2016 |
Lockhart SN, Schöll M, Mellinger TJ, Swinnerton KN, Bell RK, O'Neil JP, Janabi M, Baker SL, Jagust WJ. IC-P-193: Examining Amyloid and TAU Inter-Regional PET Association Patterns in Cognitively Normal Older Adults Alzheimer's & Dementia. 12: P139-P140. DOI: 10.1016/J.Jalz.2016.06.224 |
0.435 |
|
| 2016 |
Ossenkoppele R, Schonhaut DR, Brown J, O'Neil JP, Janabi M, Baker SL, Schöll M, Kramer J, Gorno Tempini M, Miller B, Seeley WW, Jagust WJ, Rabinovici GD. IC-P-192: TAU Covariance Patterns in ad Patients Resemble Intrinsic Connectivity Networks in Young Adults Alzheimer's & Dementia. 12: P138-P139. DOI: 10.1016/J.Jalz.2016.06.223 |
0.361 |
|
| 2016 |
Schonhaut DR, Ossenkoppele R, Bejanin A, Iaccarino L, Baker SL, Lazaris A, Cantwell A, Tammewar G, Ayakta N, Lockhart SN, Scholl M, O'Neil JP, Miller B, Jagust WJ, Rabinovici GD. IC-P-181: TAU-PET Patterns Overlap and Exceed Hypometabolism in Alzheimer's Disease Alzheimer's & Dementia. 12: P132-P133. DOI: 10.1016/j.jalz.2016.06.212 |
0.354 |
|
| 2016 |
Arenaza-Urquijo EM, Landau SM, Bell RK, Lockhart SN, Mellinger TJ, Baker SL, Chetelat G, Jagust WJ. IC-P-131: Normal Cognition Despite Very High Risk for Alzheimer’s Disease: Neuroimaging and Neuropsychological Insights Into Resilient Brain Aging Alzheimer's & Dementia. 12: P98-P99. DOI: 10.1016/J.Jalz.2016.06.161 |
0.347 |
|
| 2016 |
Schonhaut DR, Ossenkoppele R, Bejanin A, Iaccarino L, Baker SL, Lazaris A, Cantwell A, Tammewar G, Ayakta N, Lockhart S, Scholl M, O'Neil JP, Miller B, Jagust WJ, Rabinovici GD. P1-318: TAU-PET Patterns Overlap and Exceed Hypometabolism in Alzheimer's Disease Alzheimer's & Dementia. 12: P545-P547. DOI: 10.1016/J.Jalz.2016.06.1069 |
0.463 |
|
| 2015 |
Boutchko R, Mitra D, Baker SL, Jagust WJ, Gullberg GT. Clustering-initiated factor analysis application for tissue classification in dynamic brain positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 35: 1104-11. PMID 25899294 DOI: 10.1038/Jcbfm.2015.69 |
0.324 |
|
| 2015 |
Landau SM, Fero A, Baker SL, Koeppe R, Mintun M, Chen K, Reiman EM, Jagust WJ. Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 567-74. PMID 25745095 DOI: 10.2967/Jnumed.114.148981 |
0.441 |
|
| 2015 |
Ossenkoppele R, Schonhaut DR, Baker SL, O'Neil JP, Janabi M, Ghosh PM, Santos M, Miller ZA, Bettcher BM, Gorno-Tempini ML, Miller BL, Jagust WJ, Rabinovici GD. Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy. Annals of Neurology. 77: 338-42. PMID 25448043 DOI: 10.1002/Ana.24321 |
0.497 |
|
| 2015 |
Schöll M, Vogel JW, Schonhaut D, Lockhart S, Baker S, Schwimmer H, Ossenkoppele R, Rabinovici GD, Jagust WJ. Cognitive decline in healthy elderly is related to temporal lobe tau but not to cortical β-amyloid: An 18F-AV1451 and 11C-PiB PET study Alzheimers & Dementia. 11: 313-314. DOI: 10.1016/J.Jalz.2015.07.448 |
0.458 |
|
| 2015 |
Rabinovici GD, Schonhaut D, Baker S, Lazaris A, Ossenkoppele R, Lockhart S, Schöll M, Schwimmer H, Vogel JW, Ayakta N, Rosen H, Miller BL, O'Neil JP, Boxer AL, Jagust WJ. O4-01-06: Tau PET with [18
F]AV1451 in non-alzheimer's disease neurodegenerative syndromes Alzheimer's & Dementia. 11: P268-P269. DOI: 10.1016/j.jalz.2015.07.350 |
0.343 |
|
| 2015 |
Schonhaut D, Ossenkoppele R, Schöll M, Lockhart S, Baker S, Lazaris A, Cantwell A, Vogel JW, Ayakta N, Gorno-Tempini M, Miller ZA, O'Neil JP, Miller BL, Jagust WJ, Rabinovici GD. O4-01-02: Associations of [18
F]AV1451 Tau PET with age, ApoE genotype, and cognition in Alzheimer's disease Alzheimer's & Dementia. 11: P265-P266. DOI: 10.1016/j.jalz.2015.07.346 |
0.373 |
|
| 2015 |
Rabinovici GD, Schonhaut D, Baker S, Lazaris A, Ayakta N, Cantwell A, Lockhart S, Vogel JW, Schwimmer H, Schöll M, Gorno Tempini ML, Miller BL, Jagust WJ, Ossenkoppele R. F2-03-01: Tau and amyloid neuroimaging of ad phenotypes Alzheimer's & Dementia. 11: P167-P167. DOI: 10.1016/J.Jalz.2015.07.116 |
0.441 |
|
| 2015 |
Lockhart S, Schöll M, Schonhaut D, Ossenkoppele R, Vogel JW, Baker S, Schwimmer H, Rabinovici GD, Jagust WJ. Examining relations of age and beta-amyloid with tau deposition measured using 18F-AV-1451 in cognitively normal older adults Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.191 |
0.413 |
|
| 2015 |
Rabinovici GD, Schonhaut D, Baker S, Lazaris A, Ossenkoppele R, Lockhart S, Schöll M, Schwimmer H, Vogel JW, Ayakta N, Rosen H, Miller BL, O'Neil JP, Boxer AL, Jagust WJ. IC-P-161: Tau PET with [18
F]AV1451 in non-alzheimer's disease neurodegenerative syndromes Alzheimer's & Dementia. 11: P107-P109. DOI: 10.1016/J.Jalz.2015.06.184 |
0.462 |
|
| 2015 |
Schonhaut D, Ossenkoppele R, Schöll M, Lockhart S, Baker S, Lazaris A, Cantwell A, Vogel JW, Ayakta N, Gorno-Tempini M, Miller ZA, O'Neil JP, Miller BL, Jagust WJ, Rabinovici GD. IC-P-157: Associations of [18
F]AV1451 Tau PET with age, ApoE genotype, and cognition in Alzheimer's disease Alzheimer's & Dementia. 11: P105-P106. DOI: 10.1016/J.Jalz.2015.06.180 |
0.488 |
|
| 2015 |
Ossenkoppele R, Schonhaut D, Baker S, Lazaris A, Ayakta N, Cantwell A, Lockhart S, Vogel JW, Schwimmer H, Schöll M, Gorno Tempini ML, Miller BL, Jagust WJ, Rabinovici GD. IC-02-02: Distinct [18
F]AV1451 retention patterns in clinical variants of Alzheimer's disease Alzheimer's & Dementia. 11: P5-P6. DOI: 10.1016/J.Jalz.2015.06.008 |
0.391 |
|
| 2015 |
Schöll M, Schonhaut D, Lockhart S, Vogel JW, Baker S, Schwimmer H, Ossenkoppele R, Rabinovici GD, Jagust WJ. In vivo braak staging using 18F-AV1451 Tau PET imaging Alzheimers & Dementia. 11: 4. DOI: 10.1016/J.Jalz.2015.06.006 |
0.392 |
|
| 2014 |
Elman JA, Madison CM, Baker SL, Vogel JW, Marks SM, Crowley S, O'Neil JP, Jagust WJ. Effects of Beta-Amyloid on Resting State Functional Connectivity Within and Between Networks Reflect Known Patterns of Regional Vulnerability. Cerebral Cortex (New York, N.Y. : 1991). PMID 25405944 DOI: 10.1093/Cercor/Bhu259 |
0.382 |
|
| 2014 |
Elman JA, Oh H, Madison CM, Baker SL, Vogel JW, Marks SM, Crowley S, O'Neil JP, Jagust WJ. Neural compensation in older people with brain amyloid-β deposition. Nature Neuroscience. 17: 1316-8. PMID 25217827 DOI: 10.1038/Nn.3806 |
0.359 |
|
| 2014 |
Landau SM, Thomas BA, Thurfjell L, Schmidt M, Margolin R, Mintun M, Pontecorvo M, Baker SL, Jagust WJ. Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers. European Journal of Nuclear Medicine and Molecular Imaging. 41: 1398-407. PMID 24647577 DOI: 10.1007/S00259-014-2753-3 |
0.468 |
|
| 2014 |
Ghosh PM, Madison C, Santos M, Norton K, Baker S, Boxer AL, Rosen HJ, Miller ZA, Gorno-Tempini M, Miller BL, Jagust W, Rabinovici GD. IC-P-023: AMYLOID PET HAS GREATER CLINICAL IMPACT THAN FDG PET IN THE DIFFERENTIAL DIAGNOSIS OF AD AND FTD Alzheimer's & Dementia. 10: P17-P18. DOI: 10.1016/J.Jalz.2014.05.027 |
0.422 |
|
| 2013 |
Oh H, Madison C, Baker S, Jagust W. Region-specific associations of brain glucose metabolism with age and beta-amyloid deposition in normal aging Alzheimers & Dementia. 9: 393. DOI: 10.1016/J.Jalz.2013.05.773 |
0.303 |
|
| 2013 |
Oh H, Madison C, Baker S, Jagust W. Region-specific associations of brain glucose metabolism with age and beta-amyloid in normal aging Alzheimers & Dementia. 9: 110. DOI: 10.1016/J.Jalz.2013.05.194 |
0.334 |
|
| 2012 |
Mormino EC, Brandel MG, Madison CM, Marks S, Baker SL, Jagust WJ. Aβ Deposition in aging is associated with increases in brain activation during successful memory encoding. Cerebral Cortex (New York, N.Y. : 1991). 22: 1813-23. PMID 21945849 DOI: 10.1093/Cercor/Bhr255 |
0.338 |
|
| 2012 |
Mormino EC, Brandel MG, Madison CM, Rabinovici GD, Marks S, Baker SL, Jagust WJ. Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant. Neuroimage. 59: 1152-60. PMID 21884802 DOI: 10.1016/J.Neuroimage.2011.07.098 |
0.344 |
|
| 2011 |
Rosenbloom MH, Alkalay A, Agarwal N, Baker SL, O'Neil JP, Janabi M, Yen IV, Growdon M, Jang J, Madison C, Mormino EC, Rosen HJ, Gorno-Tempini ML, Weiner MW, Miller BL, et al. Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution. Neurology. 76: 1789-96. PMID 21525424 DOI: 10.1212/Wnl.0B013E31821Cccad |
0.441 |
|
| 2011 |
Mormino EC, Smiljic A, Hayenga AO, Onami SH, Greicius MD, Rabinovici GD, Janabi M, Baker SL, Yen IV, Madison CM, Miller BL, Jagust WJ. Relationships between β-amyloid and functional connectivity in different components of the default mode network in aging. Cerebral Cortex (New York, N.Y. : 1991). 21: 2399-407. PMID 21383234 DOI: 10.1093/Cercor/Bhr025 |
0.438 |
|
| 2011 |
Braskie MN, Landau SM, Wilcox CE, Taylor SD, O'Neil JP, Baker SL, Madison CM, Jagust WJ. Correlations of striatal dopamine synthesis with default network deactivations during working memory in younger adults. Human Brain Mapping. 32: 947-61. PMID 20578173 DOI: 10.1002/Hbm.21081 |
0.338 |
|
| 2010 |
Rabinovici GD, Furst AJ, Alkalay A, Racine CA, O'Neil JP, Janabi M, Baker SL, Agarwal N, Bonasera SJ, Mormino EC, Weiner MW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain : a Journal of Neurology. 133: 512-28. PMID 20080878 DOI: 10.1093/Brain/Awp326 |
0.452 |
|
| 2010 |
Rabinovici GD, Alkalay A, Rosen HJ, Furst AJ, Agarwal N, O'Neil JP, Jang JY, Growdon ME, Yen IV, Madison C, Baker SL, Gorno-Tempini ML, Seeley WW, Miller BL, Jagust WJ. IC-P-132: Comparison of [11C]PIB and [18F]FDG PET in Discriminating Alzheimer's Disease and Frontotemporal Lobar Degeneration Alzheimer's & Dementia. 6: S52-S53. DOI: 10.1016/J.Jalz.2010.05.147 |
0.447 |
|
| 2009 |
Mormino EC, Kluth JT, Madison CM, Rabinovici GD, Baker SL, Miller BL, Koeppe RA, Mathis CA, Weiner MW, Jagust WJ. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain : a Journal of Neurology. 132: 1310-23. PMID 19042931 DOI: 10.1093/Brain/Awn320 |
0.445 |
|
| 2009 |
Landau SM, Lal R, O'Neil JP, Baker S, Jagust WJ. Striatal dopamine and working memory. Cerebral Cortex (New York, N.Y. : 1991). 19: 445-54. PMID 18550595 DOI: 10.1093/Cercor/Bhn095 |
0.317 |
|
| 2008 |
Braskie MN, Wilcox CE, Landau SM, O'Neil JP, Baker SL, Madison CM, Kluth JT, Jagust WJ. Relationship of striatal dopamine synthesis capacity to age and cognition. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 14320-8. PMID 19109513 DOI: 10.1523/Jneurosci.3729-08.2008 |
0.347 |
|
| 2007 |
Boxer AL, Rabinovici GD, Kepe V, Goldman J, Furst AJ, Huang SC, Baker SL, O'neil JP, Chui H, Geschwind MD, Small GW, Barrio JR, Jagust W, Miller BL. Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease. Neurology. 69: 283-90. PMID 17636066 DOI: 10.1212/01.Wnl.0000265815.38958.B6 |
0.452 |
|
| 2007 |
Rabinovici GD, Furst AJ, O'Neil JP, Racine CA, Mormino EC, Baker SL, Chetty S, Patel P, Pagliaro TA, Klunk WE, Mathis CA, Rosen HJ, Miller BL, Jagust WJ. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology. 68: 1205-12. PMID 17420404 DOI: 10.1212/01.Wnl.0000259035.98480.Ed |
0.471 |
|
| 2006 |
Baker S, Baseler H, Klein S, Carney T. Localizing sites of activation in primary visual cortex using visual-evoked potentials and functional magnetic resonance imaging. Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society. 23: 404-15. PMID 17016150 DOI: 10.1097/01.Wnp.0000214596.69436.E0 |
0.635 |
|
| 2006 |
Teng E, Manser PT, Ward M, Sanabria-Bohorquez S, Ray R, Baker SL, Kerchner GA, Weimer R. P4-353: BASELINE TAU BURDEN MEASURED BY [18
F]GTP1 IMAGING IS ASSOCIATED WITH SUBSEQUENT COGNITIVE DECLINE IN PRODROMAL TO MILD ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P1604-P1605. DOI: 10.1016/j.jalz.2018.07.177 |
0.361 |
|
| 2006 |
Maass A, Berron D, Harrison TM, Baker SL, Mellinger TJ, Swinnerton KN, Bell RK, Düzel E, Jagust WJ. F1‐04‐04: EFFECTS OF TAU AND AMYLOID DEPOSITION MEASURED BY PET ON DOMAIN‐SPECIFIC MEMORY FUNCTION IN OLD AGE Alzheimer's & Dementia. 14. DOI: 10.1016/j.jalz.2018.06.2318 |
0.311 |
|
| 2006 |
La Joie R, Visani A, Lesman-Segev OH, Bourakova V, Baker SL, Janabi M, Miller ZA, O'Neil JP, Perry D, Pham J, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD. IC-P-145: NON-AMNESTIC PHENOTYPES OF ALZHEIMER'S DISEASE, EARLY AGE OF ONSET AND APOE GENOTYPE ARE ASSOCIATED WITH TAU, NOT Aβ-PET Alzheimer's & Dementia. 14: P123-P124. DOI: 10.1016/J.Jalz.2018.06.2211 |
0.469 |
|
| 2006 |
Cha J, Park Y, Lee J, Baker SL, Visani A, Bourakova V, Pham J, Janabi M, O'Neil JP, Miller BL, Jagust WJ, Rabinovici GD. IC-P-136: MODELING AMYLOID, TAU, AND NEURODEGENERATION ACROSS THE ALZHEIMER'S DISEASE SPECTRUM: CROSS-SECTIONAL STUDY Alzheimer's & Dementia. 14: P113-P115. DOI: 10.1016/J.Jalz.2018.06.2202 |
0.388 |
|
| 2006 |
Winer JR, Mander BA, Helfrich RF, Maass A, Harrison TM, Baker SL, Knight RT, Jagust WJ, Walker MP. IC-P-131: HUMAN IN VIVO TAU PATHOLOGY, IMPAIRED NREM SLEEP OSCILLATIONS AND MEMORY DECLINE IN AGING Alzheimer's & Dementia. 14: P108-P109. DOI: 10.1016/J.Jalz.2018.06.2197 |
0.334 |
|
| Show low-probability matches. |